Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

PharmGKB summary: very important pharmacogene information for GSTT1.

Thorn CF, Ji Y, Weinshilboum RM, Altman RB, Klein TE.

Pharmacogenet Genomics. 2012 Aug;22(8):646-51. doi: 10.1097/FPC.0b013e3283527c02. No abstract available.

2.

PharmGKB summary: very important pharmacogene information for UGT1A1.

Barbarino JM, Haidar CE, Klein TE, Altman RB.

Pharmacogenet Genomics. 2014 Mar;24(3):177-83. doi: 10.1097/FPC.0000000000000024. Review. No abstract available.

3.

PharmGKB summary: very important pharmacogene information for CYP1A2.

Thorn CF, Aklillu E, Klein TE, Altman RB.

Pharmacogenet Genomics. 2012 Jan;22(1):73-7. doi: 10.1097/FPC.0b013e32834c6efd. No abstract available.

4.

PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Barbarino JM, Kroetz DL, Klein TE, Altman RB.

Pharmacogenet Genomics. 2015 Apr;25(4):205-21. doi: 10.1097/FPC.0000000000000118. No abstract available.

5.

PharmGKB summary: very important pharmacogene information for G6PD.

McDonagh EM, Thorn CF, Bautista JM, Youngster I, Altman RB, Klein TE.

Pharmacogenet Genomics. 2012 Mar;22(3):219-28. doi: 10.1097/FPC.0b013e32834eb313. No abstract available.

6.
7.

Pharmacogenetics in cancer etiology and chemotherapy.

Boddy AV, Ratain MJ.

Clin Cancer Res. 1997 Jul;3(7):1025-30. Review. No abstract available.

8.

Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance.

Lo HW, Ali-Osman F.

Curr Opin Pharmacol. 2007 Aug;7(4):367-74. Epub 2007 Aug 6. Review.

PMID:
17681492
9.

Glutathione S-transferase (GSTM1, GSTT1 and GSTA1) polymorphisms and outcomes after treatment for acute myeloid leukemia: pharmacogenetics in Southwest Oncology Group (SWOG) clinical trials.

Weiss JR, Kopecky KJ, Godwin J, Anderson J, Willman CL, Moysich KB, Slovak ML, Hoque A, Ambrosone CB.

Leukemia. 2006 Dec;20(12):2169-71. Epub 2006 Sep 28. No abstract available.

PMID:
17008887
10.

PharmGKB: an integrated resource of pharmacogenomic data and knowledge.

Gong L, Owen RP, Gor W, Altman RB, Klein TE.

Curr Protoc Bioinformatics. 2008 Sep;Chapter 14:Unit14.7. doi: 10.1002/0471250953.bi1407s23.

11.

Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?

Stocco G, Pelin M, Franca R, De Iudicibus S, Cuzzoni E, Favretto D, Martelossi S, Ventura A, Decorti G.

World J Gastroenterol. 2014 Apr 7;20(13):3534-41. doi: 10.3748/wjg.v20.i13.3534. Review.

12.

Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin.

Kap EJ, Richter S, Rudolph A, Jansen L, Ulrich A, Hoffmeister M, Ulrich CM, Brenner H, Chang-Claude J.

Pharmacogenet Genomics. 2014 Jul;24(7):340-7. doi: 10.1097/FPC.0000000000000059.

PMID:
24842074
13.

PharmGKB summary: very important pharmacogene information for CYP3A5.

Lamba J, Hebert JM, Schuetz EG, Klein TE, Altman RB.

Pharmacogenet Genomics. 2012 Jul;22(7):555-8. doi: 10.1097/FPC.0b013e328351d47f. No abstract available.

14.
15.

PharmGKB summary: very important pharmacogene information for SLC22A1.

Goswami S, Gong L, Giacomini K, Altman RB, Klein TE.

Pharmacogenet Genomics. 2014 Jun;24(6):324-8. doi: 10.1097/FPC.0000000000000048. No abstract available.

16.

Cancer pharmacogenetics.

Marsh S, McLeod HL.

Br J Cancer. 2004 Jan 12;90(1):8-11. Review.

17.

Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics.

Moyer AM, Salavaggione OE, Hebbring SJ, Moon I, Hildebrandt MA, Eckloff BW, Schaid DJ, Wieben ED, Weinshilboum RM.

Clin Cancer Res. 2007 Dec 1;13(23):7207-16.

18.

Update on pharmacogenetics in cancer chemotherapy.

Innocenti F, Ratain MJ.

Eur J Cancer. 2002 Mar;38(5):639-44. Review.

PMID:
11916544
19.

A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes.

Schnakenberg E, Fabig KR, Stanulla M, Strobl N, Lustig M, Fabig N, Schloot W.

Environ Health. 2007 Feb 10;6:6.

20.

Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?

Ansari M, Krajinovic M.

Pharmacogenomics. 2009 Nov;10(11):1729-32. doi: 10.2217/pgs.09.135. No abstract available.

Supplemental Content

Support Center